source
- Sanofi defends Garijo appointment and reaffirms commitment to immunology ahead of new CEOSanofi held its first-quarter earnings call, with CFO François-Xavier Roger fielding questions from the media. During the call he defended the recent appointment of Belén Garijo, formerly of Merck…
- Substance-use disorder biotech Tempero Bio shuts down after serious safety incidentTempero Bio, a biotech focused on treatments for substance use disorders, announced it will cease operations. The decision follows a serious adverse event that occurred during the company's develo…